WITHDRAWN: LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma

Christopher J. Douglas(University of Minnesota), Daniela A. Bota(University of California, Irvine)

bioRxiv (Cold Spring Harbor Laboratory)

April 17, 2023

10.1101/2023.04.13.536817

Cited by 1

Related Papers

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

|Journal of Translational Medicine|2018|540

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

|JAMA Oncology|2022|411

Non-viral precision T cell receptor replacement for personalized cell therapy

|Nature|2022|276

Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma

|JAMA Oncology|2020|141

Sequential 1,2-Addition−Electrocyclic Ring Closures Involving Acyclic α,β-Unsaturated Iminiums: A Formal [3 + 3] Cycloaddition Strategy to Unique Pyranyl Spirocycles

|The Journal of Organic Chemistry|1999|89